Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Urology-Nephrology
12. July 2026
Search
medline.ch
Urology-Nephrology
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Anzeige
Zoom:
Page 1 of 23827
Articles 1 - 20 / 476540
Clinical pathological changes in prostate cancer patients after hormonal therapy: A single-center pilot study.
Biochem Biophys Rep
Magar RW, Sadeq MR, El-Halawani S, Karras MS.
PMID: 42437084 [PubMed]
Primary healthcare utilisation and associated factors among post-treatment prostate cancer survivors in Tanzania: a cross-sectional study.
Ecancermedicalscience
Nakey RR, Kwesigabo GP, Shabani MC, Ndibalema YK, Temba AJ.
PMID: 42437066 [PubMed]
An AI-powered diagnostic system for grading and invasion of non-muscle-invasive bladder cancer via TURBT specimens: A multicenter study.
iScience
Zhang X, Wang H, Zhou H, Xiao D, Xiong H, Cheng J, He Y, Feng Q, Yang J.
PMID: 42436972 [PubMed]
Advances and perspectives of functional nanomaterials in scavenging reactive oxygen species for acute kidney injury.
Bioact Mater
Luo L, Lin S, Wang L, Meng Y, Zhu M, Chen L.
PMID: 42436956 [PubMed]
Multiple myeloma with spinal involvement: Renal dysfunction and albuminuria are associated with progressive sarcopenia in a longitudinal CT morphometric study.
Brain Spine
Kylies J, Kylies D, Weisel K, Wenzel UO, Huber TB, Viezens L, Leonhardt LG.
PMID: 42436913 [PubMed]
Feasibility of contrast-enhanced ultrasound as a screening tool for patients at high risk for kidney malignancies.
Transl Androl Urol
Azarang A, Papadopoulou V, Johnson KA, Walmer RW, Olinger K, Lee E, Burke L, Chang EH.
PMID: 42436796 [PubMed]
Robotic partial nephrectomy is inching toward the gold standard for small renal masses-a narrative review.
Transl Androl Urol
Xu M, Rodriguez A, Hemal A.
PMID: 42436791 [PubMed]
Artificial intelligence and predictive tools in non-muscle invasive bladder cancer: a narrative review of current insights and advances.
Transl Androl Urol
Gabriel PE, Ingles JC, Zhu A, Horowitz A, Sfakianos JP, Xylinas E.
PMID: 42436788 [PubMed]
Digital simulation of kidney collecting system and stone: geometry and texture mapping.
Transl Androl Urol
Korkmaz N, Mondshine JA, Saini S, Ojalvo J, Khandekar A, Marcovich R, Shah HN, Visser U, Katz JE.
PMID: 42436787 [PubMed]
Real-world effectiveness of rezvilutamide plus androgen deprivation therapy in patients with high-volume metastatic hormone-sensitive prostate cancer: a retrospective multicenter cohort study.
Transl Androl Urol
Wang B, Xia D, Pan Y, Hu J, Liu H, Zhang X, Chen D, Huang H, Chen G, Fan J, Zhang H, Wu H, Li Z, Zhao G, Wang Q, Li L, Ye M, Yang G, Liu Y, Lin J, Gu Y, Liu F, Chen Z, Luo J, Wang L, Ying Z, He T, Lin C, Zhang X, Niu S.
PMID: 42436774 [PubMed]
A prediction model for targeted drug resistance in renal cell carcinoma based on plasma proteomics analysis.
Transl Androl Urol
Gan X, Yan R, Yang B, Wang J, Guo J, Wang X, Hu X, Wang L, Liu B.
PMID: 42436772 [PubMed]
Bipolar electrocautery hemostasis in sutureless laparoscopic partial nephrectomy for exophytic small renal masses under zero-ischemia: a retrospective single-center experience.
Transl Androl Urol
Xiao D, Yin N, Han B, Yang M, Li Y, Li Y, Zhou Q, Qin W, Hu X, Li Q, Xu X.
PMID: 42436767 [PubMed]
A contrast-enhanced ultrasound-based nomogram for preoperative prediction of pseudocapsule status in localized clear cell renal cell carcinoma: a retrospective study.
Transl Androl Urol
Ma J, Wang ZF, Li F, Chen J, Wu R.
PMID: 42436764 [PubMed]
Association Between Low-Dose Aspirin Use and Early Renal Injury Biomarkers in Patients with Type 2 Diabetes Mellitus: A Retrospective Matched Cohort Study.
Diabetes Metab Syndr Obes
Hsieh YS, Lin YY.
PMID: 42436762 [PubMed]
Multimodal deep learning for predicting WHO/ISUP grading in renal tumors on CT using a self-attention-based model: variable Vision Transformer (vViT).
Eur J Radiol Open
Usuzaki T, Matsuno E, Shizukuishi T, Inamori R, Zeng Y, Zhang X, Oguro S, Homma N, Takase K.
PMID: 42436714 [PubMed]
Scoping Review of Polygenic Risk Scores in Kidney-Related Traits.
Kidney Int Rep
Sugawara Y, Ito K, Iwagami M, Inokuchi R, Nihei Y, Nangaku M, Hirakawa Y.
PMID: 42436695 [PubMed]
Substaging and Stratified Treatment of T1 Bladder Cancer - a Nationwide Register-Based Study.
Eur Urol Open Sci
Nielsen NK, Hjort PB, Hansen EB, Graugaard-Jensen C, Jakobsen JK, Kingo PS, Jensen JB.
PMID: 42436677 [PubMed]
Comparative outcomes of flexible ureterorenoscopy with high-power holmium: YAG laser and flexible, navigable suction access sheath vs mini-percutaneous nephrolithotomy in 2-3Â cm kidney stones treatment: a prospective cohort study.
BMC Urol
K, Göger YE, Çavdar ÖF, Ta, Özkent MS.
PMID: 42436463 [PubMed - as supplied by publisher]
Novel phenotypic clusters of adult-onset diabetic kidney disease based on static and dynamic clustering algorithms - a data-driven multi-center study.
BMC Endocr Disord
Li K, Wei L, Yin R, Xu M, Zhao Q, Ke J, Yang L.
PMID: 42436433 [PubMed - as supplied by publisher]
Enfortumab vedotin monotherapy, enfortumab vedotin plus pembrolizumab, and immune checkpoint inhibitor-based neoadjuvant therapy for muscle-invasive bladder cancer: A systematic review and meta-analysis.
Urol Oncol
Yajima S, Yoshida S, Imasato N, Chen W, Fukushima H, Tanaka H, Masuda H, Fujii Y.
PMID: 42436099 [PubMed - as supplied by publisher]
Articles 1 - 20 / 476540
Page 1 of 23827
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy